LEDGF/p75 Is Required for an Efficient DNA Damage Response

Int J Mol Sci. 2021 May 30;22(11):5866. doi: 10.3390/ijms22115866.

Abstract

Lens epithelium-derived growth factor splice variant of 75 kDa (LEDGF/p75) plays an important role in cancer, but its DNA-damage repair (DDR)-related implications are still not completely understood. Different LEDGF model cell lines were generated: a complete knock-out of LEDGF (KO) and re-expression of LEDGF/p75 or LEDGF/p52 using CRISPR/Cas9 technology. Their proliferation and migration capacity as well as their chemosensitivity were determined, which was followed by investigation of the DDR signaling pathways by Western blot and immunofluorescence. LEDGF-deficient cells exhibited a decreased proliferation and migration as well as an increased sensitivity toward etoposide. Moreover, LEDGF-depleted cells showed a significant reduction in the recruitment of downstream DDR-related proteins such as replication protein A 32 kDa subunit (RPA32) after exposure to etoposide. The re-expression of LEDGF/p75 rescued all knock-out effects. Surprisingly, untreated LEDGF KO cells showed an increased amount of DNA fragmentation combined with an increased formation of γH2AX and BRCA1. In contrast, the protein levels of ubiquitin-conjugating enzyme UBC13 and nuclear proteasome activator PA28γ were substantially reduced upon LEDGF KO. This study provides for the first time an insight that LEDGF is not only involved in the recruitment of CtIP but has also an effect on the ubiquitin-dependent regulation of DDR signaling molecules and highlights the role of LEDGF/p75 in homology-directed DNA repair.

Keywords: CRISPR/Cas9; DNA damage signaling; LEDGF; ubiquitination; γH2AX.

MeSH terms

  • Adaptor Proteins, Signal Transducing / deficiency
  • Adaptor Proteins, Signal Transducing / genetics*
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Autoantigens / genetics
  • Autoantigens / metabolism
  • BRCA1 Protein / genetics
  • BRCA1 Protein / metabolism
  • CRISPR-Cas Systems
  • Cell Line
  • Cell Line, Tumor
  • Cell Movement / drug effects
  • Cell Proliferation / drug effects
  • DNA / genetics*
  • DNA / metabolism
  • DNA Damage
  • Epithelial Cells / cytology
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Etoposide / pharmacology
  • Gene Expression Regulation*
  • Gene Knockout Techniques
  • Histones / genetics
  • Histones / metabolism
  • Humans
  • Osteoblasts / cytology
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism
  • Proteasome Endopeptidase Complex / genetics
  • Proteasome Endopeptidase Complex / metabolism
  • Recombinational DNA Repair*
  • Replication Protein A / genetics
  • Replication Protein A / metabolism
  • Signal Transduction
  • Transcription Factors / deficiency
  • Transcription Factors / genetics*
  • Ubiquitin-Conjugating Enzymes / genetics
  • Ubiquitin-Conjugating Enzymes / metabolism

Substances

  • Adaptor Proteins, Signal Transducing
  • Antineoplastic Agents, Phytogenic
  • Autoantigens
  • BRCA1 Protein
  • BRCA1 protein, human
  • H2AX protein, human
  • Histones
  • Ki antigen
  • PSIP1 protein, human
  • Replication Protein A
  • Transcription Factors
  • Etoposide
  • DNA
  • UBE2N protein, human
  • Ubiquitin-Conjugating Enzymes
  • RPA2 protein, human
  • Proteasome Endopeptidase Complex